Related references
Note: Only part of the references are listed.The multifaceted effects of metformin on tumor microenvironment
Ivana Kurelac et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling
Xiaohong Zhang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2020)
HIV-1, HAART and cancer: A complex relationship
Anna Shmakova et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity
Louisa Nelson et al.
NATURE COMMUNICATIONS (2020)
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
K. Esther Broekman et al.
INVESTIGATIONAL NEW DRUGS (2020)
Anti -fungal drug itraconazole exerts anti -cancer e ffects in oral squamous cell carcinoma via suppressing Hedgehog pathway
Liuxian Ban et al.
LIFE SCIENCES (2020)
Human-Derived Model Systems in Gynecological Cancer Research
Kadi Lohmussaar et al.
TRENDS IN CANCER (2020)
Statin therapy and association with ovarian cancer risk in the New England Case Control (NEC) study
Babatunde Akinwunmi et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Epithelial ovarian cancer
Stephanie Lheureux et al.
LANCET (2019)
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
Patrycja Nowak-Sliwinska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances
Pouya Saraei et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Observational Studies on the Association Between Post-diagnostic Metformin Use and Survival in Ovarian Cancer: A Systematic Review and Meta-Analysis
Ting-Ting Gong et al.
FRONTIERS IN ONCOLOGY (2019)
Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs
Anna Markowska et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
The Pattern of Non-AIDS-defining Cancers in the HIV Population: Epidemiology, Risk Factors and Prognosis. A Review
Marco Franzetti et al.
CURRENT HIV RESEARCH (2019)
Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-B pathway
Lu Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
Chen Yang et al.
ONCOLOGY LETTERS (2019)
An Ex-Vivo Culture System of Ovarian Cancer Faithfully Recapitulating the Pathological Features of Primary Tumors
Farhana Ishrat Ghani et al.
CELLS (2019)
The Potential Effect of Metformin on Cancer: An Umbrella Review
Hong Yu et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells
Jingjing Liu et al.
BIOSCIENCE REPORTS (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Association of metformin use with ovarian cancer incidence and prognosis: a systematic review and meta-analysis
Jinghua Shi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers
Katharina Bischof et al.
SCIENTIFIC REPORTS (2019)
Metformin and cancer: An existing drug for cancer prevention and therapy (Review)
Fuming Zi et al.
ONCOLOGY LETTERS (2018)
Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress
Jiaqiao Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study
E. Urpilainen et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis
Danxia Chu et al.
BMC CANCER (2018)
Impact of postdiagnostic statin use on ovarian cancer mortality: A systematic review and meta-analysis of observational studies
Xia Li et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study
Ronan T. Swords et al.
LEUKEMIA RESEARCH (2018)
Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK Activation
Min-Bin Chen et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence
Burak Zeybek et al.
REPRODUCTIVE SCIENCES (2018)
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis et al.
SCIENCE (2018)
Itraconazole inhibits the proliferation of gastric cancer cells in vitro and improves patient survival
Ke Lan et al.
ONCOLOGY LETTERS (2018)
In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening
Andrea R. Mazzocchi et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
Ines Lohse et al.
PLOS ONE (2018)
Real-time assessment of platinum sensitivity of primary culture from a patient with ovarian cancer with extensive metastasis and the platinum sensitivity enhancing effect by metformin
Yingzhao Liu et al.
ONCOLOGY LETTERS (2018)
Artemisinin Derivatives and Synthetic Trioxane Trigger Apoptotic Cell Death in Asexual Stages of Plasmodium
Sarika Gunjan et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Study of New Therapeutic Strategies to Combat Breast Cancer Using Drug Combinations
Ana Correia et al.
BIOMOLECULES (2018)
Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and Angiogenesis
Sarah A. Head et al.
ACS CHEMICAL BIOLOGY (2017)
Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer
Tilley Jenkins Vogel et al.
GYNECOLOGIC ONCOLOGY (2017)
Itraconazole induces apoptosis and cell cycle arrest via inhibiting Hedgehog signaling in gastric cancer cells
Qiang Hu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert L. Coleman et al.
LANCET (2017)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2017)
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
Robert L. Coleman et al.
LANCET ONCOLOGY (2017)
Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer A retrospective study
Shan-Bing Wang et al.
MEDICINE (2017)
Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells
Xinzhe Li et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies
Ying-Ju Ou et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer
Michiko Kodama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Repurposing itraconazole for the treatment of cancer
Rachel Pounds et al.
ONCOLOGY LETTERS (2017)
Metformin in combination with cisplatin inhibits cell viability and induces apoptosis of human ovarian cancer cells by inactivating ERK 1/2
Jian-Hong Dang et al.
ONCOLOGY LETTERS (2017)
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
Yusuke Kobayashi et al.
ONCOTARGET (2017)
Statin use and survival outcomes in endocrine-related gynecologic cancers: A systematic review and meta-analysis
Weimin Xie et al.
ONCOTARGET (2017)
Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer
Sho Nambara et al.
ONCOTARGET (2017)
Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways
Guanzhao Liang et al.
ONCOTARGET (2017)
The anti-cancer effects of itraconazole in epithelial ovarian cancer
Chel Hun Choi et al.
SCIENTIFIC REPORTS (2017)
Population Impact & Efficiency of Benefit-Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease
Mark J. Pletcher et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Statin use is associated with improved survival in ovarian cancer: A retrospective population-based study
Alexandra Couttenier et al.
PLOS ONE (2017)
Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer
Elizabeth de Wolf et al.
SCIENTIFIC REPORTS (2017)
Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells
Juan Du et al.
BMC CANCER (2017)
Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage
Min Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery
Fleur Weeber et al.
CELL CHEMICAL BIOLOGY (2017)
Pre-diagnostic statin use, lymph node status and mortality in women with stages I-III breast cancer
Amelia Smith et al.
BRITISH JOURNAL OF CANCER (2017)
Ex vivo tumor culture systems for functional drug testing and therapy response prediction
Titia G. Meijer et al.
FUTURE SCIENCE OA (2017)
Itraconazole Inhibits AKT/mTOR Signaling and Proliferation in Endometrial Cancer Cells
Hiroshi Tsubamoto et al.
ANTICANCER RESEARCH (2017)
Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice
Miki Nishio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer
Jessica E. Stine et al.
ONCOTARGET (2016)
Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancer
Kui Wang et al.
AUTOPHAGY (2016)
Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress
Yingying Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
Qianhui Dou et al.
CANCER RESEARCH (2016)
Environment Dictates Dependence on Mitochondrial Complex I for NAD plus and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
Dan Y. Gui et al.
Cell Metabolism (2016)
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Xiaojing Liu et al.
Cell Metabolism (2016)
Drug combination therapy increases successful drug repositioning
Wei Sun et al.
DRUG DISCOVERY TODAY (2016)
Preclinical evaluation of olaparib and metformin combination in BRCA1 wildtype ovarian cancer
M. Hijaz et al.
GYNECOLOGIC ONCOLOGY (2016)
Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells
Luciano Galdieri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies
Thomas Knickelbine et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Association of Itraconazole, a Hedgehog Inhibitor, and Bladder Cancer
Ronac Mamtani et al.
JOURNAL OF UROLOGY (2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
M. R. Mirza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bisphosphonate use and the risk of endometrial cancer: a meta-analysis of observational studies
Ying-Ju Ou et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells
Chandan Seth et al.
PLOS ONE (2016)
YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo
Dan Sun et al.
ONCOTARGET (2016)
Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer
James B. Greenaway et al.
ONCOTARGET (2016)
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
Mina S. Ally et al.
JAMA DERMATOLOGY (2016)
Mechanisms and Targets Involved in Dissemination of Ovarian Cancer
Ulrich H. Weidle et al.
CANCER GENOMICS & PROTEOMICS (2016)
Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy
Nazzarena Labo et al.
AIDS (2015)
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
Ernst Lengyel et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models
Yusuke Kobayashi et al.
CLINICAL CANCER RESEARCH (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
Drug repurposing in oncology-patient and health systems opportunities
Francesco Bertolini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Immune-mediated antitumor effect by type 2 diabetes drug, metformin
Shingo Eikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours
Tan A. Ince et al.
NATURE COMMUNICATIONS (2015)
Metformin and epithelial ovarian cancer therapeutics
Seema Patel et al.
CELLULAR ONCOLOGY (2015)
Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44+CD117+ ovarian cancer stem cells
Rongrong Zhang et al.
STEM CELL RESEARCH & THERAPY (2015)
HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape
Virginia Carroll et al.
PATHOGENS AND DISEASE (2015)
Optimal management of cervical cancer in HIV-positive patients: a systematic review
Atara Ntekim et al.
CANCER MEDICINE (2015)
Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients
Keun-Wook Lee et al.
CLINICAL CANCER RESEARCH (2015)
Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2015)
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
David D. Bowtell et al.
NATURE REVIEWS CANCER (2015)
Impact of itraconazole after first-line chemotherapy on the survival of patients with distant metastatic biliary tract cancer
Hiroshi Tsubamoto et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Itraconazole suppresses the growth of glioblastoma through induction of autophagy Involvement of abnormal cholesterol trafficking
Rui Liu et al.
AUTOPHAGY (2014)
Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
Sara Gandini et al.
CANCER PREVENTION RESEARCH (2014)
The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis
Z. -J. Zhang et al.
DIABETES OBESITY & METABOLISM (2014)
The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
Alice Melotti et al.
EMBO MOLECULAR MEDICINE (2014)
The effect of bisphosphonates on the risk of endometrial and ovarian malignancies
Gad Rennert et al.
GYNECOLOGIC ONCOLOGY (2014)
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
Joong Sup Shim et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
Daniel J. Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Statin Use After Colorectal Cancer Diagnosis and Survival: A Population-Based Cohort Study
Chris R. Cardwell et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Use of Statins and the Risk of Death in Patients With Prostate Cancer
Oriana Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
Ya Xie et al.
MOLECULAR MEDICINE REPORTS (2014)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
Yan Xia et al.
PLOS ONE (2014)
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
William W. Wheaton et al.
ELIFE (2014)
Metformin intake is associated with better survival in ovarian cancer A Case-Control Study
Sanjeev Kumar et al.
CANCER (2013)
LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
David B. Shackelford et al.
CANCER CELL (2013)
Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
James Kim et al.
CANCER CELL (2013)
Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections
Jodi Lestner et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Preclinical evaluation of statins as a treatment for ovarian cancer
Elizabeth Robinson et al.
GYNECOLOGIC ONCOLOGY (2013)
The Effects of Metformin on Ovarian Cancer A Systematic Review
Piyemeth Dilokthornsakul et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Charles M. Rudin et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates
Naomi Gronich et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
M. A. Pierotti et al.
ONCOGENE (2013)
Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer
Emmanuel S. Antonarakis et al.
ONCOLOGIST (2013)
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Monica Franciosi et al.
PLOS ONE (2013)
Statins reduce melanoma development and metastasis through MICA overexpression
Christine Pich et al.
FRONTIERS IN IMMUNOLOGY (2013)
Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research
Nuzhat Ahmed et al.
FRONTIERS IN ONCOLOGY (2013)
Simvastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivo
H. Liu et al.
NEOPLASMA (2013)
Population PK/PD analysis of metformin using the signal transduction model
Jung-woo Chae et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Clinicopathological Features of Homologous Recombination-Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival
Asima Mukhopadhyay et al.
CANCER RESEARCH (2012)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
History of Avermectin and Ivermectin, with Notes on the History of Other Macrocyclic Lactone Antiparasitic Agents
William C. Campbell
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway
Rabbie K. Hanna et al.
GYNECOLOGIC ONCOLOGY (2012)
Metformin targets ovarian cancer stem cells in vitro and in vivo
Jessica J. Shank et al.
GYNECOLOGIC ONCOLOGY (2012)
Metformin Regulates Glucose Transporter 4 (GLUT4) Translocation through AMP-activated Protein Kinase (AMPK)-mediated Cbl/CAP Signaling in 3T3-L1 Preadipocyte Cells
Jung Ok Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Carol Aghajanian et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Therapeutic strategies in epithelial ovarian cancer
Ayako Kim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
Iris L. Romero et al.
OBSTETRICS AND GYNECOLOGY (2012)
Metformin inhibits the development and metastasis of ovarian cancer
Buchu Wu et al.
ONCOLOGY REPORTS (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak
NATURE REVIEWS CANCER (2012)
MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
Zhongwei Cao et al.
CANCER RESEARCH (2011)
Direct antitumour activity of zoledronic acid: preclinical and clinical data
Joaquim Bosch-Barrera et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
Wei Kang et al.
CLINICAL CANCER RESEARCH (2011)
Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000-2009
K. I. Kaitin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
X. Stephenne et al.
DIABETOLOGIA (2011)
Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins
Amber Yasmeen et al.
GYNECOLOGIC ONCOLOGY (2011)
Use of metformin and the risk of ovarian cancer: A case-control analysis
Michael Bodmer et al.
GYNECOLOGIC ONCOLOGY (2011)
Inflammation and the Development of Atherosclerosis -Effects of Lipid-Lowering Therapy
Yoshiko Mizuno et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2011)
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
R. Rattan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Drug repositioning: Re-investigating existing drugs for new therapeutic indications
B. M. Padhy et al.
JOURNAL OF POSTGRADUATE MEDICINE (2011)
Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma
Motoki Matsuura et al.
ONCOLOGY REPORTS (2011)
Metformin: Multi-faceted protection against cancer
Sonia Del Barco et al.
ONCOTARGET (2011)
Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
Ramandeep Rattan et al.
NEOPLASIA (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells
Sumaiya Sharmeen et al.
BLOOD (2010)
Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
Donal J. Brennan et al.
BMC CANCER (2010)
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
Anna Martirosyan et al.
BMC CANCER (2010)
The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
R. E. Coleman et al.
BRITISH JOURNAL OF CANCER (2010)
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
James Kim et al.
CANCER CELL (2010)
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells
Chiara Laezza et al.
ENDOCRINE-RELATED CANCER (2010)
Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway
Yasuhiro Kidera et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer
Bulent Karabulut et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi
Yovany Moreno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Dysregulation of the mevalonate pathway promotes transformation
James W. Clendening et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay
Louise A. Knight et al.
BMC CANCER (2009)
High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
W-F Cheng et al.
BRITISH JOURNAL OF CANCER (2009)
Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression
Hongli Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Regulation of fibronectin matrix assembly and capillary morphogenesis in endothelial cells by Rho family GTPases
Samantha Fernandez-Sauze et al.
EXPERIMENTAL CELL RESEARCH (2009)
Regulation of Glucose-6-Phosphatase Gene Expression by Insulin and Metformin
C. Mues et al.
HORMONE AND METABOLIC RESEARCH (2009)
Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells
Sanjeev Kumar et al.
MOLECULAR CANCER (2009)
An Ivermectin-Sensitive Glutamate-Gated Chloride Channel from the Parasitic Nematode Haemonchus contortus
Samantha McCavera et al.
MOLECULAR PHARMACOLOGY (2009)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Michael Gnant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The pharmacokinetics and metabolism of ivermectin in domestic animal species
Aranzazu Gonzalez Canga et al.
VETERINARY JOURNAL (2009)
Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells
Harika Atmaca et al.
EUROPEAN CYTOKINE NETWORK (2009)
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals
Jessica L. Long et al.
AIDS (2008)
The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
Mahvash Zakikhani et al.
CANCER PREVENTION RESEARCH (2008)
Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer
Akiko Horiuchi et al.
CANCER SCIENCE (2008)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21(WAF1/CIP1) pathway: Analyses using a breast cancer cell line and tumoral xenograft model
Xiaoping Yu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2008)
First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma
Ralf Schmidmaier et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AME by the addition of pravastatin to idarubicin plus high-dose Ara-C: a phase 1 study
Steven M. Kornblau et al.
BLOOD (2007)
Inhibition of angiogenesis by the antifungal drug itraconazole
Curtis R. Chong et al.
ACS CHEMICAL BIOLOGY (2007)
Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer
Stephanie Hille et al.
ANTI-CANCER DRUGS (2006)
Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir
MZ Dewan et al.
BLOOD (2006)
Lopinavir/ritonavir - A review of its use in the management of HIV infection
Vicki Oldfield et al.
DRUGS (2006)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Approaches to managing bone metastases from breast cancer: The role of bisphosphonates
K Mystakidou et al.
CANCER TREATMENT REVIEWS (2005)
Ascites induces modulation of α6β1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma
N Ahmed et al.
BRITISH JOURNAL OF CANCER (2005)
Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy
GM Clifford et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: Comparison with other class III antiarrhythmic drugs
Y Nagasawa et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix
JJ Knox et al.
EUROPEAN JOURNAL OF CANCER (2005)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells
JC Dumon et al.
EUROPEAN UROLOGY (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
The risk of cancer in users of statins
MR Graaf et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Antitumor effect of avermectins
VA Drinyaev et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): A model of the interplay of the immune system, virus, and cancer. On the offensive - The Trojan horse is being destroyed - Part B: Malignant lymphoma
TW Cheung
CANCER INVESTIGATION (2004)
Role of itraconazole in haematology/oncology
NA Pandya et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2003)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
Direct effects of bisphosphonates on breast cancer cells
SG Senaratne et al.
BREAST CANCER RESEARCH (2002)
Lovastatin induced control of blast cell growth in an elderly patient with acute myeloblastic leukemia
MD Minden et al.
LEUKEMIA & LYMPHOMA (2001)
Share Paper
